Abingdon Health Plc (ABDX)

London
7.75
+0.50(+6.90%)
  • Volume:
    394,465
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    7.75 - 7.75

ABDX Overview

Prev. Close
7.25
Day's Range
7.75-7.75
Revenue
5.63M
Open
7.25
52 wk Range
6.51-84.75
EPS
-0.09
Volume
394,465
Market Cap
9.43M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
418,629
P/E Ratio
-
Beta
-
1-Year Change
-74.49%
Shares Outstanding
121,716,822
Next Earnings Date
-
What is your sentiment on Abingdon Health?
or
Market is currently closed. Voting is open during market hours.

Abingdon Health Plc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Abingdon Health Plc Company Profile

Abingdon Health Plc Company Profile

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell